Left ventricular hypertrophy in autosomal dominant polycystic kidney disease

Area of Science:

• Nephrology
• Cardiology
• Genetics

Background:

• Cardiovascular complications are the leading cause of death in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
• Left Ventricular Hypertrophy (LVH) is a significant risk factor for cardiovascular mortality in essential hypertension.
• Hypertension is prevalent and often early-onset in ADPKD patients, but the frequency of LVH and its associations in this population remain unclear.

Purpose of the Study:

• To determine the frequency of Left Ventricular Hypertrophy (LVH) in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients.
• To investigate the relationship between LVH and cardiovascular risk factors, including hypertension, in ADPKD.
• To explore associations between LVH, renal function, and renal volume in ADPKD.

Main Methods:

• Echocardiography was performed on 116 adult ADPKD patients and 77 healthy controls.
• Demographic, clinical, and laboratory data were collected and analyzed.
• Statistical comparisons were made between ADPKD patients with and without LVH, and between ADPKD patients and controls.

Main Results:

• A significantly higher prevalence of LVH was observed in both male (46% vs. 20%) and female (37% vs. 12%) ADPKD patients compared to controls.
• LVH in ADPKD patients was associated with higher blood pressure, diminished renal function, and increased renal volume.
• ADPKD patients with LVH were older, heavier, had higher hypertension prevalence, and lower hematocrit than those without LVH.

Conclusions:

• Left Ventricular Hypertrophy (LVH) is common in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients, exceeding control group frequencies.
• LVH in ADPKD is linked to hypertension, impaired renal function, and larger kidney size.
• The contribution of blood pressure to LVH in ADPKD may be exacerbated by early onset and inadequate treatment of hypertension.